Candel Therapeutics Inc (CADL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 26,746 | 16,284 | 15,752 | 13,207 | 11,177 |
| Operating Income | -26,746 | -16,284 | -15,752 | -13,207 | -11,177 |
| Interest Expense | 1,575 | 1,564 | 1,416 | 161 | 236 |
| Other Income | -10,584 | 8,987 | -12,328 | 2,099 | 6,617 |
| Pre-tax Income | -38,905 | -8,861 | -29,496 | -11,269 | -4,796 |
| Net Income Continuous | -38,905 | -8,861 | -29,496 | -11,269 | -4,796 |
| Net Income | $-38,905 | $-8,861 | $-29,496 | $-11,269 | $-4,796 |
| EPS Basic Total Ops | -0.52 | -0.14 | -0.57 | -0.21 | -0.09 |
| EPS Basic Continuous Ops | -0.52 | -0.14 | -0.57 | -0.21 | -0.09 |
| EPS Diluted Total Ops | -0.52 | -0.14 | -0.55 | -0.21 | -0.09 |
| EPS Diluted Continuous Ops | -0.52 | -0.14 | -0.56 | -0.21 | -0.09 |
| EPS Diluted Before Non-Recurring Items | -0.35 | -0.14 | -0.54 | -0.21 | -0.09 |
| EBITDA(a) | $-26,575 | $-16,135 | $-15,589 | $-13,012 | $-10,935 |